+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Human Embryonic Stem Cells Market - Growth, Trends, and Forecast (2020 - 2025)

  • PDF Icon


  • 110 Pages
  • September 2020
  • Region: Global
  • Mordor Intelligence
  • ID: 4591631
UP TO OFF until Sep 30th 2023
The government funding for the development of regenerative medicine has been increasing in most developed countries, because of its applications in organ transplantation, tissue engineering, and various other applications. In the United States, two major government agencies, National Institutes of Health (NIH) and California Institute of Regenerative Medicine (CIRM), fund almost all the translational researches and regenerative medicine development in the country. It is estimated that the United States government invests around USD 800-900 million every year in stem cell research. Additionally, other factors such as the high prevalence of cardiac and malignant diseases, and rising demand for regenerative medicines are expected to drive the market.

Key Market Trends

Stem Cell Biology Research Segment is Expected to Show Better Growth in the Forecast Years

Based on the application, it is segmented into regenerative medicine, stem cell biology research, tissue engineering, and toxicology testing. Stem cell biology research will show better growth, owing to the high prevalence of cardiac and malignant diseases. An article published by the ISSCR (International Society for Stem Cell Research) reported that the stem cells hold potential for the treatment of Parkinson’s disease in humans. Recently, one of the market players, International Stem Cell Corporation (ISCO), received the patent covering methods for generating HLA homozygous parthenogenetic human stem cell lines from unfertilized eggs. The patent was issued in Australia. Furthermore, to boost the pace of stem cell research, the government is providing funding opportunities to researchers. Thus, owing to these factors, the market studied is expected to witness a high growth rate over the forecast period.

North America Dominates the Human Embryonic Stem Cells Market

The human embryonic stem cells market is expected to dominate in the North America region owing to extensive research activities, along with high burden of chronic diseases and genetic disorders in the region. The United States also shows a high incidence of other diseases, such as diabetes, heart disease, renal failure, and osteoporosis. Human embryonic stem cells have high potential for use in treatment and may become a standard of care for these diseases. Additionally, the FDA has approved clinical trials, which indicated the use of stem cells. Hence, these factors are expected to influence the growth of the human embryonic stem cells market over the forecast period.

Competitive Landscape

The global players into the human embryonic stem cells market are Astellas Pharma Inc, PeproTech Inc, Lineage Cell Therapeutics Inc, Merck KGaA, PromoCell GmbH, STEMCELL Technologies Inc, Thermo Fisher Scientific and ViaCyte, Inc.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence of Cardiac and Malignant Diseases
4.2.2 Rising Demand for Regenerative Medicines
4.2.3 Increasing Support from Governments and Government and Private Institutions
4.3 Market Restraints
4.3.1 High Cost of the Procedure
4.3.2 Stringent Regulatory Guidelines
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Application
5.1.1 Regenerative Medicine
5.1.2 Stem Cell Biology Research
5.1.3 Tissue Engineering
5.1.4 Toxicology Testing
5.2 Geography
5.2.1 North America United States Canada Mexico
5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.2.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.2.4 Rest of World
6.1 Company Profiles
6.1.1 Astellas Pharma Inc
6.1.2 PeproTech Inc
6.1.3 Lineage Cell Therapeutics Inc
6.1.4 Merck KGaA
6.1.5 PromoCell GmbH
6.1.6 STEMCELL Technologies Inc
6.1.7 Thermo Fisher Scientific
6.1.8 ViaCyte, Inc.
6.1.9 Takara Bio Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Astellas Pharma Inc
  • PeproTech Inc
  • Lineage Cell Therapeutics Inc
  • Merck KGaA
  • PromoCell GmbH
  • STEMCELL Technologies Inc
  • Thermo Fisher Scientific
  • ViaCyte, Inc.
  • Takara Bio Inc.